{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:09:15Z","timestamp":1792098555522,"version":"4.4.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Primary aldosteronism is the most common and modifiable form of secondary hypertension. Left untreated, primary aldosteronism leads high rates of cardiovascular, metabolic, and kidney disease. Therefore, early diagnosis and targeted therapy are crucial to improve long-term patient outcomes. In the case of unilateral primary aldosteronism, surgical adrenalectomy is the guideline-recommended treatment of choice as compared to alternative medical therapies such as mineralocorticoid receptor antagonist medications. Surgical adrenalectomy is not only highly successful in reversing the biochemical abnormalities inherent to primary aldosteronism, but also in mitigating the long-term risks associated with this disease. Indeed, as opposed to medical treatment alone, surgical adrenalectomy offers the potential for disease cure. Within this review article, we review the existing evidence highlighting the benefits of surgical over medical treatment for unilateral primary aldosteronism.<\/jats:p>","DOI":"10.3389\/fendo.2022.861581","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T07:54:17Z","timestamp":1650959657000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism"],"prefix":"10.3389","volume":"13","author":[{"given":"Sumaiya","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Hundemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The Unrecognized Prevalence of Primary Aldosteronism: A Cross-Sectional Study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary Aldosteronism and Hypertensive Disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"B4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective Study on the Prevalence of Secondary Hypertension Among Hypertensive Patients Visiting a General Outpatient Clinic in Japan","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive Patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00139","article-title":"The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment","volume":"39","author":"Vaidya","year":"2018","journal-title":"Endocr Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004100878","article-title":"Relative Glomerular Hyperfiltration in Primary Aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.115.07074","article-title":"Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors","volume":"67","author":"Briet","year":"2016","journal-title":"Hypertension"},{"key":"B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/01.HYP.0000078357.92682.EC","article-title":"Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling","volume":"42","author":"Pu","year":"2003","journal-title":"Hypertension"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10437","article-title":"Smooth Muscle Cell-Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging","volume":"71","author":"Kim","year":"2018","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2891","article-title":"Direct Regulation of Blood Pressure by Smooth Muscle Cell Mineralocorticoid Receptors","volume":"18","author":"McCurley","year":"2012","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06172","article-title":"Endothelial Mineralocorticoid Receptors Differentially Contribute to Coronary and Mesenteric Vascular Function Without Modulating Blood Pressure","volume":"66","author":"Mueller","year":"2015","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"crossref","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an Increased Rate of Cardiovascular Events in Patients With Primary Aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2805","article-title":"Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001251","article-title":"Plasma Aldosterone Level Within the Normal Range is Less Associated With Cardiovascular and Cerebrovascular Risk in Primary Aldosteronism","volume":"35","author":"Murata","year":"2017","journal-title":"J Hypertens"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/BF03347840","article-title":"Vascular Complications in Patients With Aldosterone Producing Adenoma in Japan: Comparative Study With Essential Hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan","volume":"18","author":"Takeda","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic Outcomes and Mortality in Medically Treated Primary Aldosteronism: A Retrospective Cohort Study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"32103","DOI":"10.1038\/srep32103","article-title":"Long Term Outcome of Aldosteronism After Target Treatments","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816121-00032","article-title":"Left Ventricular Systolic Function in Primary Aldosteronism and Hypertension","volume":"16","author":"Rossi","year":"1998","journal-title":"J Hypertens"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.27.5.1039","article-title":"Changes in Left Ventricular Anatomy and Function in Hypertension and Primary Aldosteronism","volume":"27","author":"Rossi","year":"1996","journal-title":"Hypertension"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"key":"B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular Events and Target Organ Damage in Primary Aldosteronism Compared With Essential Hypertension: A Systematic Review and Meta-Analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-013-1007-x","article-title":"Elevated Prevalence of Abnormal Glucose Metabolism in Patients With Primary Aldosteronism: A Meta-Analysis","volume":"183","author":"Chen","year":"2014","journal-title":"Ir J Med Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0450","article-title":"Increased Prevalence of Diabetes Mellitus and the Metabolic Syndrome in Patients With Primary Aldosteronism of the German Conn's Registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","journal-title":"JCI Insight"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001361","article-title":"Risk of New-Onset Diabetes Mellitus in Primary Aldosteronism: A Population Study Over 5 Years","volume":"35","author":"Wu","year":"2017","journal-title":"J Hypertens"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0031","article-title":"Primary Aldosteronism in Diabetic Subjects With Resistant Hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1293","article-title":"High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan","volume":"42","author":"Akehi","year":"2019","journal-title":"Diabetes Care"},{"key":"B34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","article-title":"Effects of Aldosterone on Insulin Sensitivity and Secretion","volume":"91","author":"Luther","year":"2014","journal-title":"Steroids"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","article-title":"Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans","volume":"75","author":"Adler","year":"2020","journal-title":"Hypertension"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz293","article-title":"Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension","volume":"105","author":"Hu","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3867","article-title":"Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity","volume":"102","author":"Hundemer","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1851","article-title":"Risk Factors Associated With a Low Glomerular Filtration Rate in Primary Aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal Damage in Primary Aldosteronism: Results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-Term Renal Outcomes in Patients With Primary Aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283495cbb","article-title":"Primary Aldosteronism: Changes in Cystatin C-Based Kidney Filtration, Proteinuria, and Renal Duplex Indices With Treatment","volume":"29","author":"Wu","year":"2011","journal-title":"J Hypertens"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.06.012","article-title":"Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism","volume":"5","author":"Kobayashi","year":"2020","journal-title":"Kidney Int Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal Damage in Primary Aldosteronism: A Systematic Review and Meta-Analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"key":"B46","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/000313480006601005","article-title":"Laparoscopic Adrenalectomy is Superior to an Open Approach to Treat Primary Hyperaldosteronism","volume":"66","author":"Duncan","year":"2000","journal-title":"Am Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64028-1","article-title":"Laparoscopic Management of Primary Hyperaldosteronism: Clinical Experience With 212 Cases","volume":"169","author":"Meria","year":"2003","journal-title":"J Urol"},{"key":"B48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000313480206800307","article-title":"Primary Hyperaldosteronism in the Era of Laparoscopic Adrenalectomy","volume":"68","author":"Rossi","year":"2002","journal-title":"Am Surg"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and Genetic Causes of Idiopathic Hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2986","article-title":"Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism","volume":"102","author":"Yamazaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13006","article-title":"Sex Difference in the Association Between Subtype Distribution and Age at Diagnosis in Patients With Primary Aldosteronism","volume":"74","author":"Akasaka","year":"2019","journal-title":"Hypertension"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism: An International Consensus on Outcome Measures and Analysis of Remission Rates in an International Cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002070","article-title":"Clinical and Biochemical Outcomes After Adrenalectomy and Medical Treatment in Patients With Unilateral Primary Aldosteronism","volume":"37","author":"Katabami","year":"2019","journal-title":"J Hypertens"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2017.10.045","article-title":"Analysis of Postoperative Biochemical Values and Clinical Outcomes After Adrenalectomy for Primary Aldosteronism","volume":"163","author":"Swearingen","year":"2018","journal-title":"Surgery"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-019-05265-8","article-title":"Outcomes After Surgery for Unilateral Dominant Primary Aldosteronism in Sweden","volume":"44","author":"Sellgren","year":"2020","journal-title":"World J Surg"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2020.07.046","article-title":"Long-Term Outcome Success After Operative Treatment for Primary Aldosteronism","volume":"169","author":"Picado","year":"2021","journal-title":"Surgery"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14176","article-title":"Appropriate Timing for a Biochemical Evaluation After Adrenalectomy for Unilateral Aldosterone-Producing Adenoma","volume":"92","author":"Takamatsu","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900552","article-title":"Success of Surgery for Primary Aldosteronism Judged by Residual Autonomous Aldosterone Production","volume":"22","author":"Rutherford","year":"1998","journal-title":"World J Surg"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","article-title":"Vascular Remodeling and Duration of Hypertension Predict Outcome of Adrenalectomy in Primary Aldosteronism Patients","volume":"51","author":"Rossi","year":"2008","journal-title":"Hypertension"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1067\/msy.1998.93108","article-title":"Essential Hypertension: First Reason for Persistent Hypertension After Unilateral Adrenalectomy for Primary Aldosteronism","volume":"124","author":"Proye","year":"1998","journal-title":"Surgery"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1763","article-title":"Improved Quality of Life, Blood Pressure, and Biochemical Status Following Laparoscopic Adrenalectomy for Unilateral Primary Aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031337","article-title":"Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers From Five Continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcw194","article-title":"Clinical Outcomes Following Unilateral Adrenalectomy in Patients With Primary Aldosteronism","volume":"110","author":"Hannon","year":"2017","journal-title":"QJM"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13131","article-title":"Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function","volume":"74","author":"Kobayashi","year":"2019","journal-title":"Hypertension"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.5842","article-title":"Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism","volume":"154","author":"Vorselaars","year":"2019","journal-title":"JAMA Surg"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-4-200108210-00010","article-title":"Primary Aldosteronism: Factors Associated With Normalization of Blood Pressure After Surgery","volume":"135","author":"Sawka","year":"2001","journal-title":"Ann Intern Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1996.01430180072015","article-title":"Factors Influencing Outcome of Surgery for Primary Aldosteronism","volume":"131","author":"Celen","year":"1996","journal-title":"Arch Surg"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.06.014","article-title":"Association of Kidney Function With Residual Hypertension After Treatment of Aldosterone-Producing Adenoma","volume":"54","author":"Group","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0018","article-title":"Renin, a Marker for Left Ventricular Hypertrophy, in Primary Aldosteronism: A Cohort Study","volume":"185","author":"Kohler","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00019","article-title":"Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism","volume":"3","author":"Chen","year":"2019","journal-title":"J Endocr Soc"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15328","article-title":"Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success","volume":"76","author":"Peng","year":"2020","journal-title":"Hypertension"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of Life in Patients With Bilateral Primary Aldosteronism Before and During Treatment With Spironolactone and\/or Amiloride, Including a Comparison With Our Previously Published Results in Those With Unilateral Disease Treated Surgically","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment","volume":"103","author":"Velema","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B78","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12893-018-0432-1","article-title":"Effect of Unilateral Adrenalectomy on the Quality of Life of Patients With Lateralized Primary Aldosteronism","volume":"18","author":"Citton","year":"2019","journal-title":"BMC Surg"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.861581\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T13:52:42Z","timestamp":1675432362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.861581\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":78,"alternative-id":["10.3389\/fendo.2022.861581"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.861581","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"article-number":"861581"}}